Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxygen-hydrogen inhalation to prevent reperfusion injury during primary angioplasty
2012-004406-10Phase 2Completed
- Sponsor
- Fakultní nemocnice Hradec Králové
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of oxygen-hydrogen gas mixture in myocardial infarction (MI) and ischemia-reperfusion injury (IRI) (2 arms), sponsored by Fakultní nemocnice Hradec Králové. Primary endpoint: Efficacy on residual myocardial damage. Started Jul 2013; status: completed.
02
Drugs
oxygen-hydrogen gas mixture
03
Conditions
myocardial infarction (MI)ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on 2012-004406-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004406-10.